CREO MEDICAL Financials

CREO MEDICAL's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CREO MEDICAL volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on CREO MEDICAL GRP correlated with the market. If Beta is less than 0 CREO MEDICAL generally moves in the opposite direction as compared to the market. If CREO MEDICAL Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CREO MEDICAL GRP is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CREO MEDICAL is generally in the same direction as the market. If Beta > 1 CREO MEDICAL moves generally in the same direction as, but more than the movement of the benchmark.